Morgan Stanley Finance LLC Launches Dual Directional Buffered PLUS Securities Linked to S&P 500 Futures Index

Structured Product Design and Leverage Mechanics

The Dual Directional Buffered PLUS securities represent a multi-component structured investment combining debt and performance-based elements linked to the S&P 500 Futures Excess Return Index. The securities employ a 116% leverage factor on upside performance, meaning investors receive 1.16 times the percentage gain if the index rises above its initial strike level of 596.71 recorded on July 17, 2026. This leverage structure is intended to amplify returns during favorable market conditions while maintaining principal protection within specified bounds. The pricing supplement indicates the securities are unsecured obligations of Morgan Stanley Finance LLC, fully and unconditionally guaranteed by Morgan Stanley, with no interest payments during the three-year holding period.

The leverage mechanism applies exclusively to upside scenarios where the final index level exceeds the initial strike level at maturity on July 24, 2029. If the index closes higher on the observation date of July 17, 2029, each investor will receive their stated principal amount of $1,000 plus a leveraged upside payment calculated as the stated principal multiplied by the 116% leverage factor multiplied by the index's percentage change. The filing states this structure allows investors to capture enhanced gains from equity market appreciation, though it inherently involves complexity and operational features that differ substantially from conventional fixed-income securities.

Buffer Protection and Downside Loss Scenarios

The securities incorporate a buffer mechanism set at 80% of the initial index level, calculated as 477.368 points. This buffer design creates distinct payment outcomes depending on where the final index level falls at maturity. If the index declines but remains at or above the buffer level—meaning it has fallen no more than 20% from its strike price—investors receive their full principal amount plus a positive return equal to the absolute value of the index's percentage decline multiplied by a 100% absolute return participation rate. The filing explains that under these circumstances, the maximum positive return is effectively limited to 20%, aligning with the buffer threshold.

However, if the final index level falls below the 477.368 buffer level, investors face principal loss on a one-to-one basis for each percentage point the index declines beyond the 20% buffer cushion. The payment at maturity in this scenario is calculated as the stated principal amount multiplied by the performance factor (final level divided by initial level) plus the 20% buffer amount. The disclosure emphasizes that "the payment at maturity will be less, and may be significantly less, than the stated principal amount," though a minimum payment floor of 20% of the stated principal amount ($200 per security) applies. This means investors cannot lose more than 80% of their initial investment under any circumstances.

Pricing and Embedded Costs

The securities carry an issue price of $1,000 per security, with an aggregate principal amount of $100,000 for this offering tranche. However, the pricing supplement discloses an estimated value on the pricing date of $956.50 per security, reflecting embedded costs associated with issuing, selling, structuring, and hedging the securities. These costs, borne by investors, represent a 43.50 basis point spread between the issue price and fair value. Selected dealers and their financial advisors will collectively receive fixed sales commissions of $30 per security sold, with total agent commissions and fees of $3,000 across the offering, and net proceeds to Morgan Stanley Finance LLC of $97,000 from the $100,000 aggregate principal.

The filing explains that the estimated value calculation incorporates Morgan Stanley's own pricing and valuation models, market inputs, assumptions regarding the underlier, volatility factors, current and expected interest rates, and an interest rate related to the company's secondary market credit spread. The disclosure notes that Morgan Stanley uses an internal funding rate in determining economic terms, which is "likely to be lower than our secondary market credit spreads and therefore advantageous to us." The supplement states that if structuring and hedging costs were lower or if the internal funding rate were higher, one or more economic terms would be more favorable to investors. Secondary market pricing, absent market changes, may differ from the estimated value and reflect both the company's secondary market credit spread and bid-offer spreads applied by the agent in secondary market transactions.

Credit Risk and Investor Protections

The securities are unsecured obligations backed solely by Morgan Stanley's full and unconditional guarantee, meaning investors assume the full credit risk of both Morgan Stanley Finance LLC and its parent, Morgan Stanley. The pricing supplement explicitly states that "all payments are subject to our credit risk," warning that in the event of default, investors could lose some or all of their investment. The securities carry no security interest in, or access to, any underlying reference assets, distinguishing them from secured debt instruments that pledge collateral. The filing indicates the securities are not insured by the Federal Deposit Insurance Corporation or any other governmental agency and are not obligations of or guaranteed by any bank, contrary to deposit products.

Investors are required to accept the risk of losing a significant portion of their initial investment as a condition of purchasing these securities. The disclosure emphasizes multiple times that these are "principal at risk securities" suitable only for investors willing to forgo current income and accept substantial downside exposure in exchange for potential leveraged upside gains and partial downside buffering. The guarantor, Morgan Stanley, is an investment-grade financial institution, but guarantee strength depends on Morgan Stanley's financial condition and creditworthiness at any given time.

Index Performance and Observation Mechanics

The Dual Directional Buffered PLUS securities track the S&P 500 Futures Excess Return Index, with an initial level established at 596.71 on the strike date of July 17, 2026. The final level at maturity will be determined by the closing level of the underlier on the observation date of July 17, 2029, subject to postponement for non-trading days and certain market disruption events as specified in the accompanying product and index supplements. This three-year observation period means investors will not receive any interim payments or dividends during the holding period, with all returns concentrated at maturity.

The index used for these securities is the S&P 500 Futures Excess Return Index rather than the standard S&P 500 Price Index, a distinction that may affect return calculations and index tracking compared to conventional S&P 500 investments. The filing notes that investors should consult the accompanying product supplement, index supplement, tax supplement, and prospectus for detailed definitions and methodologies governing index calculation, adjustments, and disruption events that could affect the final observation and payment calculations.

Investor Suitability and Risk Considerations

According to the pricing supplement, these securities are designed specifically for investors who seek returns based on underlier performance and are willing to risk principal and forgo current income in exchange for three distinct features: the upside leverage mechanism, the absolute return participation in downside scenarios above the buffer level, and the downside buffer itself. The disclosure states the securities are "for investors who seek a return based on the performance of the underlier and who are willing to risk their principal and forgo current income," emphasizing that investor suitability hinges on comfort with complex payoff structures and substantial downside risk.

The supplement highlights that these securities involve risks not associated with ordinary debt securities, requiring investors to understand the interaction between leverage, buffering, and the three-year time horizon. The securities are not listed on any securities exchange, meaning investors cannot easily exit their positions prior to maturity through public markets. Investors considering these securities should carefully evaluate whether the potential for leveraged gains justifies the downside risk profile and illiquidity characteristics, and whether the 20% principal loss buffer adequately addresses their risk tolerance for a three-year locked-in investment.

Registration and Regulatory Framework

This pricing supplement, numbered 17,284, was filed pursuant to SEC Rule 424(b)(2) on July 17, 2026, and references registration statement numbers 333-293641 and 333-293641-01. The securities are issued as part of Morgan Stanley Finance LLC's Series A Global Medium-Term Notes program, an established platform for structured debt offerings. The filing includes cross-references to a product supplement dated April 8, 2026, an index supplement dated April 8, 2026, a tax supplement dated April 8, 2026, and a prospectus dated April 8, 2026, which together form the complete disclosure document for these securities.

The SEC and state securities regulators have not approved or disapproved the securities or determined whether the documents are truthful or complete, as is standard for structured product offerings. Investors should review all accompanying documents to fully understand the terms, tax implications, and risks before making investment decisions. The securities are identified by CUSIP 61781G2W0 and ISIN US61781G2W09 for trading and settlement purposes.

Morgan Stanley & Co. as Agent and Potential Conflicts of Interest

Morgan Stanley & Co. LLC ("MS & Co.") serves as the agent for this offering and is identified as an affiliate of Morgan Stanley Finance LLC and a wholly owned subsidiary of Morgan Stanley. This relationship creates potential conflicts of interest, as the agent is compensated for sales activities and may also be involved in secondary market trading of the securities. The pricing supplement directs investors to review supplemental information regarding the plan of distribution and conflicts of interest, as well as detailed disclosures in the accompanying product supplement regarding conflicts and the agent's role in hedging activities.

The agent's compensation structure includes the fixed sales commission of $30 per security paid to selected dealers and their financial advisors, with the total agent compensation across the $100,000 offering equaling $3,000. Beyond sales commissions, Morgan Stanley may profit from hedging activities associated with these securities and from secondary market bid-offer spreads if it acts as a principal buyer or seller of the securities following issuance. Investors should carefully consider these compensation arrangements and potential incentives that may influence recommendations or market-making activities.

Tax and Legal Considerations

The pricing supplement references a tax supplement dated April 8, 2026, which the filing indicates contains detailed information regarding the U.S. federal income tax treatment of the securities. Investors should consult this supplement carefully, as well as their own tax advisors, to understand the tax consequences of purchasing, holding, and eventually receiving payment on these principal-at-risk securities. The tax treatment of structured products may be complex and could differ materially depending on individual investor circumstances and any changes in tax law during the three-year holding period.

The securities' legal documentation is comprehensive, with multiple supplemental documents forming the complete offering materials. The filing cautions investors to "read this document together with the related product supplement, index supplement, tax supplement and prospectus," emphasizing that no single document contains all necessary information for informed decision-making. Investors who purchase these securities should maintain documentation of their tax basis and transaction details for filing requirements and potential future audits or amendments to tax law that could affect the securities' treatment.